The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.
What is hantavirus, and how do you get it and treat it? What to know about the disease that killed Gene Hackman's wife Betsy ...
NIH-Sponsored Trial of Lassa Vaccine Opens - Viral Hemorrhagic Disease Can be Fatal & Causes Permanent Hearing Loss ...
said the U.S. Centers for Disease Control and Prevention The viruses can cause hantavirus pulmonary syndrome, what Arakawa ...
New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...
Known as severe fever with thrombocytopenia syndrome, or SFTS, the highly fatal viral hemorrhagic fever spreads to humans through ixodid ticks, which are typically found in mountains, forests and ...
Lassa fever vaccine is one step closer to approval. Lassa virus infections, primarily spread by rodents, can cause a fatal ...
An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback